Abstract:
The present invention relates to a composition to a nutritional composition comprising 0.1 to 15 gram fermentable partially hydrolysed gum having a degree of polymerisation between 10 and 300 per 100 gram dry weight of the composition and 0.1 to 15 gram fermentable, indigestible polysaccharide other than a hydrolysed gum having a DP between 10 and 300 per 100 gram dry weight of the composition.
Abstract:
The invention relates to a mixture of carbohydrates which is characterized in that it contains or is composed of two different and essentially soluble carbohydrate constituents A and B which remain undigested in the gastrointestinal tract and reach the large intestine without being resorbed. The carbohydrate constituent A consists of at least one monosaccharide or at least one oligosaccharide while the carbohydrate constituent B consists of a polysaccharide (heptasaccharide upwards) or a mixture of at least two polysaccharides. At least 80 wt. % of the carbohydrate constituents A and B have a prebiotic action.
Abstract:
A method is provided for reducing the duration of diarrhea and recurrent episodes of diarrhea in humans by enterally administering indigestible oligosaccharides prophylactically. More specifically, the present invention relates to a method using indigestible oligosaccharides or fructooligosaccharides (FOS) to reduce the duration and recurrence of diarrhea in a human wherein between 0.5 grams and 5 grams of at least one FOS selected from the group consisting of 1-kestose, nystose, and 1F-β-fructofuranosyl nystose is administered to said human per day. The indigestible oligosaccharides can be produced through enzymatic synthesis, chemical techniques or isolated from plant materials and are administered in the form of a nutritional product, candy, tablets, chewing gum, lozenges, milk, yogurts, fermented products and the like.
Abstract:
The present invention relates to a nutritional composition comprising at least one sialylated oligosaccharide, for use in reducing and/or avoiding excessive fat mass accumulation, in preventing the associated later in life health disorders like later in life obesity and related comorbidities, in reducing and/or controlling food intake and/or in promoting a healthy growth in an infant or a young child.
Abstract:
A selection of strains of lactic bacteria and bifidobacteria of human intestinal origin capable of metabolizing oxalates is described. Moreover, a food composition or supplement product or pharmaceutical composition containing said bacterial strains is also described.
Abstract:
Disclosed are compositions comprising synergic combinations of xyloglucans and plant or animal proteins, which are useful in the treatment of intestinal disorders.